Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
44 Cards in this Set
- Front
- Back
What is another name for type I hypersensitivity disorders?
|
anaphylactic type
|
|
What is the basic sequence of events in type I hypersensitivity reactions?
|
-antigen stimulates TH2 cells to produce cytokines (IL-4, IL-5), which stimulates B cells to make IgE
-IgE binds to high affinity Fc receptors of basophils and mast cells -upon 2nd exposure, antigen reacts w/and crosslinks bound IgE -results in degranulation and release of histamine, production of cytokines, and activation of phospholipase A2 |
|
What effect do histamine and other vasoactive substances have on the body?
|
cause vasodilation, vascular leakage, and smooth muscle spasm (occurs 5-30mins after exposure)
|
|
What is the "late-phase" of type I hypersensitivity reactions?
|
2-8days later, recruitment/infiltration of eosinophils, neutrophils, basophils, monocytes; tissue damage
*see tissue and peripheral blood eosinophilia* |
|
What are some examples of local type I hypersensitivity reactions?
|
allergic/atopic rxns: seasonal rhinitis (hay fever), allergic asthma, urticaria (hives)
|
|
What are the symptoms associated with systemic anaphylaxis?
|
(aka anaphylactic shock)
rapid urticaria, bronchospasm, laryngeal edema, and shock |
|
What are the "secondary mediators" of an anaphylactic reaction?
|
leukotrienes B4, C4, D4, prostaglandin D2, PAF (all produced from activation of arachidonic acid pathway), and cytokines (to contribute to immune response)
|
|
What is another name for type II hypersensitivity disorders?
|
cytotoxic, or antibody dependent
|
|
What is the key characteristic of the antigens in type II hypersensitivity reactions?
|
they are INTRINSIC TO THE CELL OR TISSUE that is damaged (usu either altered or normal cell membrane components)
|
|
What are the 3 different types of antibody dependent hypersensitivity reactions?
|
1. complement-fixing antibodies
2. antibody-dependent cell-mediated cytotoxicity (ADCC) 3. reaction of anti-receptor antibodies with cell-surface receptors |
|
What happens in complement-mediated cytotoxicity?
|
antibody reacts with cell surface antigen, leading to fixation of complement and cell lysis (also opsonizes cells for phagocytosis)
|
|
What are the common examples of complement-mediated cytotoxicity?
|
-autoimmune hemolytic anemia (develop antibodies against your OWN blood)
-hemolytic transfusion reactions (incompatible ABO) -erythroblastosis fetalis(rhesus incompatibility) -Goodpasture syndrome (antibodies against glomerular and pulmonary alveolar basement membranes) |
|
What happens in antibody-dependent cell-mediated cytotoxicity (ADCC)?
|
antibody binds to integral cell surface antigen, and cytotoxic leukocytes then react with the Fc portion, which lyse target (usu NK cells, but also monocytes, neutrophils, and eosinophils)
|
|
What happens in antibody-mediated cellular dysfunction?
|
antibodies form against integral surface receptors that impair or dysregulate fn (w/o causing inflammation or injury)
|
|
What are the most common forms of antibody-mediated cellular dysfunction?
|
Graves disease -> antibodies stimulate TSH receptor, causing glandular hyperplasia and hyperthyroidism
Myasthenia gravis -> antibodies against ACh receptor in motor end plates cause muscle weakness |
|
What is another name for type III hypersensitivity reactions?
|
immune complex mediated reactions
|
|
What is the key characteristic of the antigen in type III reactions that differs from the antigen in type II reactions?
|
type III: antigen is NOT an intrinsic component of target cells (but can be endogenous or exogenous)
type II: antigen must be intrinsic component of target cells |
|
What is the basic mechanism of type III hypersensitivity reactions?
|
1. antigen stimulates antibody production, and antigen-antibody complexes are formed in circulation
2. antigen-Ab complexes get deposited in tissues (vessel walls, serosal surfaces, extravascular sites) 3. initiates inflammatory reaction |
|
What are the 3 main components/pathways that contribute to the inflammatory response in type III hypersensitivity reactions?
|
1. complement activation
2. platelet aggregation 3. activation of Hageman factor (XII) |
|
What are the downstream effects of complement activation in type III reactions?
|
release anaphylatoxins (C3a/C5a) -> release vasoactive amines -> vasodilation and edema
release chemotactic factors (C5a) -> attracts neutrophils -> phagocytose the complexes -> release lysosomal enzymes -> necrosis |
|
What are the downstream effects of platelet aggregation in type III reactions?
|
microthrombi formation -> ischemia -> necrosis
|
|
What are the downstream effects of the activation of Hageman factor in type III reactions?
|
microthrombi formation -> ischemia -> necrosis
activation of kinins -> vasodilation and edema |
|
Why don't these antigen-antibody complexes get removed by mononuclear phagocytotic cells, like normal?
|
smaller immune complexes are less readily removed, sometimes there is overload or dysfn of mononuc phagocytotic system
|
|
What are some examples of type III hypersensitivity reactions?
|
-serum sickness (react a/g horse serum; systemic deposition complexes esp in heart, joints, kidney)
-systemic lupus erythematosus (also multisystemic) -arthus reaction (local) -polyarteritis nodosa (generalized, involving small/medium arteries) -immune complex-mediated glomerular diseases |
|
What is the Arthus reaction?
|
localized area of tissue necrosis from acute immune complex vasculitis; exogenous antigen is introduced (injection or transplant) and reacts w/PREFORMED antibodies
|
|
What are some different types of immune-complex mediated glomerular diseases?
|
poststreptococcal glomerulonephritis, membranous glomerulonephritis, lupus nephropathy
|
|
What is another name for type IV hypersensitivity reactions?
|
cell-mediated
|
|
What are the 2 main types of cell mediated hypersensitivity reactions?
|
delayed-type (mediated by CD4 cells) and CTL-mediated cytotoxicity (mediated by CD8 cells)
|
|
What is the mechanism in delayed-type hypersensitivity?
|
1st exposure: antigen recognition, results in memory TH1 CD4 cells
re-exposure: memory TH1 cells proliferate and s/c cytokines (e.g. IFN-gamma, IL-2) |
|
What is the typical histological appearance of a delayed-type hypersensitivity reaction?
|
proliferation of lymphocytes, monocytes, neutrophils, w/accumulations around small vessels (called "cuffing"), w/induration (hardening) due to fibrin formation
|
|
What are some examples of delayed-type hypersensitivity reactions?
|
tuberculin reaction, contact dermatitis (from delayed-hypersensitivity or direct chemical injury to skin)
|
|
What is the mechanism of CTL-mediated cytotoxicity?
|
sensitized CD8 T cells directly kill target cells w/antigen presented by self MHC class I (typically tumor or virus-infected cells)
(kill using perforin or Fas/apoptosis pathway) |
|
What happens during hyperacute rejection?
|
antibody-mediated; preformed antibodies react immediately w/donor antigen and localized Arthus reaction follows (acute inflam, fibrinoid necrosis of small vessels, thrombosis)
|
|
What happens during acute cellular rejection?
|
days to months later; T-cell mediated, w/infiltration of lymphocytes and macrophages; if no arteritis, can respond promptly to immunosuppressants
|
|
What happens during acute humoral rejection (rejection vasculitis)?
|
antibody-mediated mechanisms cause vascular damage due to deposition of Ig's and complement, w/thrombosis and cortical necrosis
|
|
What happens during chronic rejection?
|
antibody-mediated vascular damage (vascular fibrointimal prolif), causes tubular atrophy and kidney shrinkage;
occurs months to years later; presents w/rise in serum creatinine over past 4-6mo |
|
What is graft vs. host disease?
|
donor's T/B cells react a/g "foreign" host cells; CD8 cells damage directly, CD4 cells recruit macrophages, which damage host
|
|
In what clinical scenarios is graft vs host disease commonly seen?
|
-bone marrow transplantation (of immunocompetent cells),
-whole blood transfusion in patients with SCID |
|
What are the principal target organs of graft-versus-host disease?
|
liver, skin, GI mucosa
|
|
What are the common presenting sx of graft-versus-host disease?
|
fever, rash, hepatosplenomegaly
|
|
Which types of sensitivity reactions involve complement?
|
II, III
|
|
Which types of sensitivity reactions are antibody mediated?
|
I, II, III
|
|
What are the common manifestations of type IV sensitivity reactions?
**4 T's** |
T lymphocytes, Transplant rejections, TB skin tests, Touching (contact dermatitis)
|
|
What is the pneumonic for hypersensitivity reactions I through IV?
|
ACID: Anaphylactic and Atopic (I), Cytotoxic (II), Immune complex (III), Delayed (cell-mediated) (IV)
|